A phase II study to evaluate the relationship between Tau Pathology and Progression of Alzheimer's Disease

Trial Profile

A phase II study to evaluate the relationship between Tau Pathology and Progression of Alzheimer's Disease

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 09 Sep 2016

At a glance

  • Drugs Flortaucipir-F-18 (Primary)
  • Indications Alzheimer's disease
  • Focus Diagnostic use
  • Most Recent Events

    • 09 Sep 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top